Phaos Technology Holdings (Cayman) (POAS) Invested Capital (2024 - 2025)

Phaos Technology Holdings (Cayman) (POAS) posted Invested Capital of $56951.0 for Q4 2025, up 36.89% on a QoQ basis from $41604.3 in Q2 2025.

Phaos Technology Holdings (Cayman) (POAS) Invested Capital (2024 - 2025) Analysis & Trends

Phaos Technology Holdings (Cayman)'s Invested Capital history runs 2 years deep, the most recent figure standing at $56951.0 for Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Abbott Laboratories	181.39 Bn	174.10 Bn	6.27 Bn	4.41 Bn
2	Stryker	128.38 Bn	125.50 Bn	3.81 Bn	499.00 Mn
3	Medtronic	107.68 Bn	98.46 Bn	6.41 Bn	1.79 Bn
4	Boston Scientific	67.98 Bn	66.53 Bn	3.61 Bn	41.00 Mn
5	Edwards Lifesciences	47.81 Bn	44.13 Bn	1.29 Bn	-
6	GE HealthCare Technologies	28.53 Bn	26.25 Bn	1.98 Bn	7.00 Mn
7	Dexcom	28.35 Bn	27.24 Bn	750.30 Mn	-
8	Smith & Nephew	26.78 Bn	26.20 Bn	-	15.00 Mn
9	Koninklijke Philips	25.34 Bn	22.21 Bn	2.07 Bn	1.41 Bn
10	Phaos Technology Holdings (Cayman)	6.05 Mn	5.99 Mn	-	56,951.00

Download Data